Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and α2-macroglobulin receptor in human breast carcinomas

International Journal of Cancer

Volumn 66, Issue 4, 1996, Pages 441-452

  Christensen, Lise ^a,b   Wiborg Simonsen, Anna Carina ^c   Heegaard, Christian W ^c   Moestrup, Søren K ^c   Andersen, Johan A ^d   Andreasen, Peter A ^c  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; BREAST CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; HUMANS; IMMUNOHISTOCHEMISTRY; LDL-RECEPTOR RELATED PROTEIN 1; LYMPHATIC METASTASIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; URINARY PLASMINOGEN ACTIVATOR;

EID: 0029992385     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960516)66:4<441::AID-IJC6>3.0.CO;2-W     Document Type: Article

References (50)

1. ANDREASEN, P.A., GEORG, B., LUND, L.R., RICCIO, A. and STACEY, S.N., Plasminogen-activator inhibitors: hormonally regulated serpins. Mol. cell. Endocrinol., 68, 1-19 (1990).
2. ANDREASEN, P.A., NIELSEN, L.S., KRISTENSEN, P., GRØNDAHL-HANSEN, J., SKRIVER, L. and DANØ, K., Plasminogen-activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator but not its pro-enzyme. J. biol. Chem., 261, 7644-7657 (1986).
3. ANDREASEN, P.A., SOTTRUP-JENSEN, L., KJØLLER, L., NYKJÆR, A., MOESTRUP, S.K., PETERSEN, C.M. and GLIEMANN, J., Receptor-mediated endocytosis of plasminogen activators and activator/ inhibitor complexes. FEBS Lett., 338, 239-245 (1994).
4. BIANCHI, E., COHEN, R.L., DAI, A., THOR, A.T., SHUMAN, M.A. and SMITH, H.S., Immunohistochemical localization of the plasminogen-activator inhibitor-1 in breast cancer. Int. J. Cancer, 60, 597-603 (1995).
5. BIANCHI, E., COHEN, R.L., THOR, AT., TODD, R.F., MIZUKAMI, I.F., LAWRENCE, D.A., LJUNG, B.M., SHUMAN, M.A. and SMITH, H.S., The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res., 54, 861-66 (1994).
6. BLASI, F., Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. BioEssays, 15, 105-11 (1993).
7. BLOOM, H.J.G. and RICHARDSON, W.W., Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Brit. J. Cancer, 11, 359-77 (1957).
8. BUSSO, N., HUARTE, J., VASALLI, J.P., SAPPINO, A.P. and BELIN, D., Plasminogen activators in the mouse mammary gland. Decreased expression during lactation. J. biol. Chem., 264, 7455-7457 (1989).
9. CARRIERO, M.V., FRANCO, P., DEL VECCHIO, S., MASSA, O., BOTTI, G., D'AIUTO, G., STOPPELLI, M.P. and SALVATORE, M., Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res., 54, 5445-5454 (1994).
10. CLAVEL, C., CHAVANEL, G. and BIREMBAUT, P., Detection of the plasmin system in human mammary pathology using immunofluorescence. Cancer Res., 46, 5743-5747 (1986).
11. COSTANTINI, V., ZACHARSKI, L.R., MEMOLI, V.A., KUDRYK, B.J., ROUSSEAU, S.M. and STUMP, D.C., Occurrence of components of fibrinolysis pathways in situ in neoplastic and non-neoplastic human breast tissue. Cancer Res., 51, 354-58 (1991).
12. DAMJANOVICH, L., TURZO, C. and ADANY, R., Factors involved in the plasminogen-activation system in human breast tumours. Thromb. Haemostas., 71, 684-91 (1994).
13. DANØ, K., ANDREASEN, P.A., GRØNDAHL-HANSEN, J., KRISTENSEN, P., NIELSEN, L.S. and SKRIVER, L., Plasminogen activators, tissue degradation and cancer. Advanc. Cancer Res., 44, 139-266 (1985).
14. DEL VECCHIO, S., STOPPELLI, M.P., CARRIERO, M.V., FONTI, R., MASSA, O., LI, P.Y., BOTTI, G., CERRA, M., D AIUTO, G., ESPOSITO, G. and SALVATORE, M., Human-urokinase-receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: Comparison with urokinase levels. Cancer Res., 53, 3198-3206 (1993).
15. DUFFY, M.J., REILLY, D., O'GRADY, P., O'HIGGINS, N., FENNELLY, J.J. and ANDREASEN, P.A., Tissue-type and urokinase-type plasminogen activator as prognostic markers in breast cancer. In: P. Glas-Greenwalt (ed.), Fibrinolysis in disease, pp. 14-18, CRC Press, New York (1995).
16. DUGGAN, C.J., MAGUIRE, T., O'HIGGINS, N., FENNELLY, J.J. and DUFFY, M.J., Urokinase-plasminogen activator and urokinase-plasminogen-activator receptor in breast cancer. Int. J. Cancer, 61, 597-600 (1995).
17. ESTREICHER, A., MÜHLHAUSER, J., CARPENTIER, J.-P., ORZI, L. and VASSALLI, J.-D., The receptor for urokinase-type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme-inhibitor complexes. J. Cell Biol., 111, 783-92 (1990).
18. FOX, S.B., LEEK, R.D., SMITH, K., HOLLYER, J., GREENALL, M. and HARRIS, A.L., Tumor angiogenesis in node-negative breast carcinomas-relationship with epidermal-growth-factor receptor, estrogen receptor and survival. Breast Cancer Res. Treatm., 29, 109-116 (1994).
19. GANESH, S., SIER, C.F.M., HEERDING, M.H., GRIFFIONEN, G., LAMERS, C. and VERSPAGET, H.W., Urokinase receptor and colorectal-cancer survival. Lancet, 344, 401-402 (1994).
20. GRØNDAHL-HANSEN, J., PETERS, H.A., VAN PUTTEN, W.L.J., LOOK, M.P., PAPPOT, H., RØNNE, E., DANØ, K., KLIJN, J.G.H., BRÜNNER, N. and FOEKENS, J.A., Prognostic significance of the receptor for urokinase-plasminogen activator in breast cancer. Clin. Cancer Res., 1, 1079-1087 (1995).
21. GRØNDAHL-HANSEN, J., RALFKIÆR, E., NIELSEN, L.S., KRISTENSEN, P., FRANTZ, G. and DANØ, K., Immunohistochemical localization of urokinase- and tissue-type-plasminogen activators in psoriatic skin. J. invest. Dermatol., 88, 28-32 (1987).
22. HEEGAARD, C.W., WIBORG SIMONSEN, A.C., OKA, K., KJØLLER, L., CHRISTENSEN, A., MADSEN, B., ELLGAARD, L., CHAN, L. and ANDREASEN, P.A., Very-low-density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen-activator/type-1 plasminogen-activator inhibitor complex. J. biol. Chem., 270, 20855-20861 (1995).
23. 2MR/LRP random fragment library. In: S.F. Schlossman, L. Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T.T. Tedder and R.F. Todd (eds.), Leucocyte typing V, pp. 975-978, Oxford University Press, Oxford (1995).
24. JANICKE, F., SCHMITT, M., PACHE, L., ULM, K., HARBECK, N., HØFLER, H. and GRAEFF, H., Urokinase (uPA) and its inhibitor are strong prognostic factors in node-negative breast cancer. Breast Cancer Res. Treatm., 24, 195-208 (1993).
25. JANKUN, J., MERRICK, H.W. and GOLDBLATT, P.J., Expression and localization of elements of the plasminogen-activation system in benign breast disease and breast cancers. J. cell. Biochem., 53, 35-44 (1993).
26. KRISTENSEN, P., PYKE, C., LUND, L.R., ANDREASEN, P.A. and DANØ, K., Plasminogen-activator inhibitor-type 1 in Lewis lung carcinoma. Histochemistiy, 93, 559-556 (1990).
27. LARSSON, L.-I., SKRIVER, L., NIELSEN, L., GRØNDAHL-HANSEN, J., KRISTENSEN, P. and DANØ, K., Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse. J. Cell Biol., 98, 894-903 (1984).
28. MIGNATTI, P. and RIFKIN, D.B., Biology and biochemistry of proteinases on tumor invasion. Physiol. Rev., 73, 161-195 (1993).
29. 2MR/LRP) cluster workshop report. In: S.F. Schlossman, L. Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T.T. Tedder and R.F. Todd (eds.), Leucocyte typing V, pp. 971-975, Oxford University Press, Oxford (1995).
30. 2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein in human tissues. Cell Tissue Res., 269, 375-382 (1992).
31. MUNCH, M., HEEGAARD, C.W. and ANDREASEN, P.A., Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitor. Biochim. biophys. Acta, 1202, 29-37 (1993).
32. MUNCH, M., HEEGAARD, C.W., JENSEN, P.H. and ANDREASEN, P.A., J., Type-1 inhibitors of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies. FEBS Lett., 295, 102-106 (1991).
33. NIELSEN, L.S., ANDREASEN, P.A., GRØNDAHL-HANSEN, J., HUANG, J.-Y., KRISTENSEN, P. and DANØ, K., Monoclonal antibodies to human M, 54,000-molecular-weight plasminogen-activator inhibitor from fibrosarcoma cells-inhibitory neutralization and one-step affinity purification. Thromb. Haemostas., 55, 206-212 (1986a).
34. NIELSEN, L.S., GRØNDAHL-HANSEN, J., ANDREASEN, P.A., SKRIVER, L., ZEUTHEN, J. and DANØ, K., Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its pro-enzyme using a combination of monoclonal and polyclonal antibodies. J. Immunoassay, 7, 209-228 (1986b).
35. 2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein. J. biol. Chem., 269, 25668-25676 (1994).
36. NYKJÆR, A., MUNCK PETERSEN, C., CHRISTENSEN, E.I., DAVIDSEN, O. and GLIEMANN, J., Urokinase receptors in human monocytes. Biochim. biophys. Acta, 1052, 399-407 (1990).
37. 2-macroglobulin-receptor/LDL-receptor-related protein binds urokinase-plasminogen-activator inhibitor type-1 complex. J. biol. Chem., 267, 14543-46 (1992).
38. PEDERSEN, H., BRÜNNER, N., FRANCIS, D., ØSTERLIND, K., RØNNE, E., HANSEN, H.H., DANØ, K. and GRONDAHL-HANSEN, J., Prognostic impact of urokinase, urokinase receptor and type-1-plasminogen-activator inhibitor in squamous and large-cell-lung-cancer tissue. Cancer Res., 54, 4671-4671 (1994).
39. PEPPER, M.S., SAPPINO, A.-P., MONTESANO, R., ORCI, L. and VASSALLI, J.-D., Plasminogen-activator inhibitor type-1 is induced in migrating endothelial cells. J. cell. Physiol., 153, 129-39 (1992).
40. PEPPER, M.S., SAPPINO, A.-P., STÖCKLIN, R., MONTESANO, R., ORCI, L. and VASSALLI, J.-D., Up-regulation of urokinase-receptor expression in migrating endothelial cells. J. Cell Biol., 122, 673-684 (1993).
41. PYKE, C., GRÆM, N., RALFKIÆR, E., RØNNE, E., HØYER-HANSEN, G., BRÜNNER, N. and DANØ, K., Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res., 53, 1911-1915 (1993).
42. PÖLLÄNEN, J., SAKSELA, O., SALONEN, E.-M., ANDREASEN, P.A., NIELSEN, L.S., DANØ, K. and VAHERI, A., Distinct localizations of urokinase-type plasminogen activator and its type-1 inhibitor under cultured human fibroblasts and sarcoma cells. J. Cell Biol., 104, 1085-1096 (1987).
43. REILLY, D., CHRISTENSEN, L., DUCH, M., NOLAN, N., DUFFY, M.J. and ANDREASEN, P.A., Type-1 plasminogen-activator inhibitor in human breast carcinomas. Int. J. Cancer, 50, 208-14 (1992).
44. STEPHENS, R.W., BOKMAN, A.M., MYÖHÖNEN, H.T., REISBERG, T., TAPIOVAARA, H., PEDERSEN, N., GRØNDAHL-HANSEN, J., LLINAS, M. and VAHERI, A., Heparin binding to the urokinase kringle domain. Biochemistry, 31, 7572-7579 (1992).
45. TISSOT, J.-D., HAUERT, J. and BACHMANN, F., Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas. Int. J. Cancer, 34, 295-302 (1984).
46. TODD, R.F., BARNATHAN, E.S., BOHUSLAV, J., CHAPMAN, H.A., COHEN, R.L., FELEZ, J., HOWELL, A., JOHNSON, J.G., KNAPP, W., KRAMER, M., MILES, L.A., NYKJÆR, A., RALFSKIÆR, E. and SCHUREN, E., CD87 (u-PAR) Cluster Workshop Report. In: S.F. Schlossman, L. Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T.T. Tedder and R.F. TODD (EDS.), LEUCOCYTE TYPING V, PP. 932-939, OXFORD UNIVERSITY PRESS, OXFORD (1995).
47. VISSCHER, D.W., SARKAR, F., LOROSSO, P., SAKR, W., OTTOSEN, S., WYKES, S. and CRISSMAN, J.D., Immunohistologic evaluation of invasion-associated proteases in breast carcinoma. Modern Pathol., 6, 302-306 (1993).
48. WEI, Y., WALTZ, D.A., RAO, N., DRUMMOND, R.J., ROSENBERG, S. and CHAPMAN, H.A., Identification of the urokinase receptor as adhesion receptor for vitronectin. J. biol. Chem., 269, 32380-32388 (1994).
49. WIBORG SIMONSEN, A.C., HEEGAARD, C.W., RASMUSSEN, L.K., ELLGAARD, L., KJØLLER, L., CHRISTENSEN, A., ETZERODT, M. and ANDREASEN, P.A., Very-low-density lipoprotein receptor from mammary gland and mammary epithelial cell lines binds and mediates endocytosis of Mr 40,000-receptor-associated protein. FEBS Lett., 354, 279-283 (1994).
50. WORLD HEALTH ORGANIZATION, Histological typing of breast tumours, 2nd ed., International histological classification of tumours, WHO, Geneva (1981).